MedTrace Logo

The Treatment of Magnesium Sulfate and Nifedipine in Preterm Labor Threat

NCT05520021 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-09-15

No results posted yet for this study

Summary

Comparison of the effects of Nifedipine and MgSO4 therapies on maternal and fetal blood flow.

Conditions

  • Preterm Labor Without Delivery
  • Pregnancy Preterm

Interventions

DRUG

Nifedipine

A total of 30 pregnancies with preterm labor threats will be treated with Nifedipine.

DRUG

Magnesium sulfate

A total of 30 pregnancies with preterm labor threats will be treated with Magnesium sulfate.

Sponsors & Collaborators

  • Konya Meram State Hospital

    lead OTHER

Principal Investigators

  • Hasan A Inal · Antalya Training and Research Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2022-12-31
Completion
2023-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05520021 on ClinicalTrials.gov